Allspring Global Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Allspring Global Investments's ABBV Position: Q1 2026 in Review
Allspring Global Investments increased its AbbVie (ABBV) stake by 0.49% in Q1 2026, buying an estimated $481K and bringing the position to 441,647 shares worth $94.9M. The position accounts for 0.16% of the portfolio, ranked #150.
Allspring Global Investments first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $281M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Allspring Global Investments held 441,647 shares of AbbVie worth $94.9M as of Q1 2026.
- Allspring Global Investments bought 2,169 AbbVie shares in Q1 2026, an estimated $481K.
- AbbVie made up 0.16% of Allspring Global Investments's portfolio in Q1 2026, its #150 holding.
- Allspring Global Investments first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's AbbVie position peaked at $281M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.